You have read all your free articles, to continue reading subscribe to read the rest of this content.
EMA’s human medicines committee (CHMP) has issued advice on the use of Merck's (known as MSD outside the United States and Canada) Lagevrio (also known as molnupiravir or MK 4482) for the treatment of COVID-19. The medicine, which is currently not authorized in the EU, can be used to treat…
The Technical University of Denmark (DTU) Bioengineering has together with collaborators received funding to develop a test kit for the new coronavirus and the first results are promising. Together with DTU Food, Statens Serum Institute (SSI), Amager, Hvidovre Hospitaler and TATAA Biocenter the pAlready a subscriber Login You have read…
A small trial shows that the anticancer drug bevacizumab is extremely effective in reducing severe COVID-19 symptoms. The results have been published in Nature Communications and the Novo Nordisk Foundation has reported about the findings. “The results are very promising. We hope that this iniAlready a subscriber Login You have…
Aztiq Pharma Partners, a private equity fund led by Róbert Wessman, announced in the beginning of July that it has completed a 100 million USD financing to purchase a newly issued share equity in Alvogen US. Morgan Stanley led the financing, which was subscribed by international institutional inAlready a subscriber…
